Large-scale testing (Phase 3)Study completedNCT01484977What this trial is testingEValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetamWho this might be right forEpilepsy UCB Pharma 120
Testing effectiveness (Phase 2)Ended earlyNCT05493293What this trial is testingExtension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset SeizuresWho this might be right forFocal Onset SeizureFocal Onset Epilepsy Neurocrine Biosciences 82
Testing effectiveness (Phase 2)Study completedNCT02170077What this trial is testingA Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093Who this might be right forEpilepsy Bial - Portela C S.A. 144
Post-approval studies (Phase 4)Ended earlyNCT01546688What this trial is testingEvaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial SeizuresWho this might be right forEpilepsy Eisai Limited 41
Large-scale testing (Phase 3)Study completedNCT00425282What this trial is testingThe Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.Who this might be right forEpilepsyEpilepsy, FocalSeizure Disorder+2 more SK Life Science, Inc. 566
Large-scale testing (Phase 3)Study completedNCT01618695What this trial is testingA Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset SeizuresWho this might be right forPartial-onset Seizures Eisai Co., Ltd. 940
Large-scale testing (Phase 3)Study completedNCT01262677What this trial is testingOnce-A-Day Pregabalin For Partial SeizuresWho this might be right forPartial SeizuresEpilepsies, Partial Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Large-scale testing (Phase 3)Study completedNCT01191086What this trial is testingOpen-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset SeizuresWho this might be right forEpilepsy Upsher-Smith Laboratories 210
Testing effectiveness (Phase 2)Study completedNCT00236860What this trial is testingThe Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresWho this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Testing effectiveness (Phase 2)Ended earlyNCT02625090What this trial is testingAn Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyWho this might be right forHighly Drug-resistant Focal Epilepsy UCB Biopharma SRL 42
Not applicableStudy completedNCT04770337What this trial is testingPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal EpilepsyWho this might be right forRefractory EpilepsyFocal SeizureSeizures, Focal+4 more Neuroelectrics Corporation 127
Testing effectiveness (Phase 2)Looking for participantsNCT05518578What this trial is testingSafety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant EpilepsyWho this might be right forEpilepsySeizures, Epileptic Supernus Pharmaceuticals, Inc. 60
Large-scale testing (Phase 3)Study completedNCT01228747What this trial is testingA Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)Who this might be right forEpilepsyGeneralized Tonic-Clonic Seizures UCB Japan Co. Ltd. 361
Large-scale testing (Phase 3)Study completedNCT00141336What this trial is testingTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.Who this might be right forSeizure Disorder, Partial Pfizer 750
Large-scale testing (Phase 3)Ended earlyNCT00698581What this trial is testingA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresWho this might be right forEpilepsy UCB Pharma 88
Large-scale testing (Phase 3)Study completedNCT02849626What this trial is testingPerampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic SeizuresWho this might be right forPartial-Onset or Primary Generalized Tonic-Clonic Seizures Eisai Inc. 180
Large-scale testing (Phase 3)Study completedNCT01284556What this trial is testingEvaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset SeizuresWho this might be right forEpilepsy West-Ward Pharmaceutical 314
Large-scale testing (Phase 3)Ended earlyNCT00310388What this trial is testingOpen-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097Who this might be right forEpilepsy GlaxoSmithKline 376
Testing effectiveness (Phase 2)Study completedNCT03373383What this trial is testingStudy to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyWho this might be right forDrug-resistant EpilepsyFocal-Onset Seizures UCB Biopharma S.P.R.L. 411
Large-scale testing (Phase 3)Study completedNCT00236886What this trial is testingProspective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsWho this might be right forEpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49